The most important financial indicators for the company Medical Oncology Research Srl - Unique Identification Number 36326327:
sales in 2023 was
70.426
euro, registering a net profit of
46.538
euro and having an average number of
1
employees.
Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala specializata having the NACE code 8622.
Sales, Profit, Employees, Debts, Capitals, Financial Results -
Medical Oncology Research Srl
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Sales - EUR
-
-
7.452
28.358
59.440
110.319
64.796
44.023
58.999
70.426
Total Income - EUR
-
-
7.452
28.358
59.440
110.319
64.934
44.280
61.180
70.476
Total Expenses - EUR
-
-
549
98
692
562
13.168
14.379
14.884
23.233
Gross Profit/Loss - EUR
-
-
6.904
28.260
58.747
109.757
51.766
29.901
46.297
47.243
Net Profit/Loss - EUR
-
-
6.680
27.409
56.964
106.448
49.932
28.580
44.992
46.538
Employees
-
-
0
0
0
0
0
0
0
1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded.
In the last year of activity, the sales increased by 19.7%, from 58.999 euro in the year 2022, to 70.426 euro in 2023.
The Net Profit increased by 1.683 euro, from 44.992 euro in 2022, to 46.538 in the last year.
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Medical Oncology Research Srl - CUI 36326327
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Fixed Assets
-
-
0
0
0
585
34.123
25.892
20.579
12.466
Current Assets
-
-
6.915
27.840
57.074
112.120
47.684
38.806
85.718
85.752
Inventories
-
-
0
0
0
704
0
0
0
0
Receivables
-
-
0
1.538
37
76.222
13.864
7.353
35.631
4.369
Cash
-
-
6.915
26.302
57.037
35.193
33.821
31.453
50.086
81.383
Shareholders Funds
-
-
6.725
27.453
57.007
106.490
51.035
38.053
45.041
56.469
Social Capital
-
-
45
44
43
42
41
40
41
40
Debts
-
-
190
387
67
6.214
30.773
26.645
61.256
42.313
Income in Advance
-
-
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
4.4821
Main CAEN
"8622 - 8622"
CAEN Financial Year
8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
85.752 euro in 2023 which includes Inventories of
0 euro, Receivables of
4.369 euro and cash availability of
81.383 euro.
The company's Equity was valued at
56.469 euro, while total Liabilities amounted to
42.313 euro.
Equity increased by 11.564 euro, from 45.041 euro in 2022, to 56.469 in 2023.
Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Medical Oncology Research Srl